Skip to main content
. 2020 Feb 17;37(4):1279–1301. doi: 10.1007/s12325-020-01251-y

Fig. 4.

Fig. 4

Changes in alcoholic liver disease and diabetes parameters in patients with diabetes and alcoholic liver disease receiving standard treatment alone (untreated) or with concomitant silymarin (treated) [59]. a Plasma malondialdehyde levels (a marker of membrane peroxidation); b glycosylated hemoglobin; c average daily insulin dose. aP < 0.05 vs. untreated control group; bP < 0.01 vs. untreated control group.

Reproduced with permission from Velussi et al. [59]